依达拉奉联合奥扎格雷钠治疗急性大面积脑梗死疗效观察

Therapeutic observation of edaravone and ozagrel-sodium in the treatment of acute massive cerebral infarction

目的探讨依达拉奉联合奥扎格雷钠治疗急性大面积脑梗死的临床疗效。方法分析本院急性大面积脑梗死患者60例临床资料,依据治疗方式不同分为观察组(依达拉奉联合奥扎格雷钠治疗组)30例和对照组(巴曲酶治疗组)30例。结果观察组急性大面积脑梗死患者神经功能缺损评分和临床治疗总有效率均明显优于对照组,P<0.05,差异均有统计学意义。结论依达拉奉联合奥扎格雷钠治疗急性大面积脑梗死神经功能改善良好,效果明显,值得临床推广应用。

Objective To observe the therapeutic effects of edaravone and ozagrel-sodium in the treatment of acute massive cerebral infarction. Methods Clinical data from 60 patients with acute massive cerebral infarction treated in our hospital were collected and were divided into observation group （patients in which were given with edaravone and -sodium） and control group （patients in which were given with batroXobin） with 30 patients in each group. Re- suits Statistically significant differences （P 〈 0.05） existed in items as acute massive cerebral infarction neurologic im- pairment score and total effective rate of clinical treatment in which observation group showed better results. Conclu- -sodium approach can effectively improve the neuron function in the treatment of acute massive cerebral infarction and is worthy of clinical application.